ISRG Stock Analysis: Buy, Sell, or Hold?

ISRG - Intuitive Surgical Inc.

ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
$356.83
19.33 (5.73%) ▲
5d: +1.04%
30d: -10.72%
90d: -26.0%
BUY
MODERATE Confidence
Analysis Updated: Jul 27, 2026 12:00 AM ET
Earnings: Oct 20, 2026
Smart Money Accumulation

None View Scanner →

Strength: 6.9/10

Get Alerted When ISRG Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
💡 BUY OPPORTUNITY: ISRG shows positive signals but monitor for confirmation. Market pricing in 13.9% decline. Moderate conviction.
See Forward Earnings Fair Value & Price Prediction →

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$434.78
Based on 7.7% avg growth
INTRINSIC VALUE TODAY
$269.96
Trading above historical range

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: ISRG is currently trading at $356.83, which is considered oversold relative to its 30-day fair value range of $360.46 to $419.41. From a valuation perspective, the stock is trading at a discount (Forward PE: 27.6) compared to its historical average (43.3). Remarkably, the market is currently pricing in an annual earnings decline of 13.9% over the next few years. This pessimistic expectation contrasts with the company's recent 26.5% earnings growth, suggesting potential undervaluation if the company simply maintains stability.

Technical Outlook: Technically, ISRG is in a strong downtrend. Immediate support is located at $328.57, while resistance sits at $405.50. The stock is showing strong short-term momentum, up 5.7% recently.

Market Sentiment: ISRG has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $490.47 (+47.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.

Quick Decision Summary

Current Position OVERSOLD
Historical Trading Range $360.46 - $419.41
Company Quality Score 42/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 61.9%

All Signals

  • BULLISH: Price oversold vs 30-day range
  • BEARISH: Weak technical setup (25/100)
  • BULLISH: High volume confirmation
  • BULLISH: Strong upward momentum (+5.7%)
  • BULLISH: Trading 47.7% below Wall St target ($490.47)

Trading Range Analysis

30-Day Trading Range $360.46 - $419.41
Current vs Trading Range OVERSOLD

Support & Resistance Levels

Support Level $328.57
Resistance Level $405.50
Current Trend Strong Downtrend
Technical data as of Jul 27, 2026

Fundamental Context

Forward P/E (Next Year Est.) 27.62
Wall Street Target $490.47 (+47.7%)
Revenue Growth (YoY) 18.5%
Earnings Growth (YoY) 26.5%
Profit Margin 28.4%
Valuation Discount vs History -13.9% cheaper
PE vs Historical 27.6 vs 43.3 CHEAP
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): -13.9% (market-implied from PE analysis)
1-Year Target $298.82 (-10%)
2-Year Target $268.94 (-19%)
3-Year Target $242.04 (-27%)
3-Yr Target (if PE normalizes) (PE: 28→43) $379.41 (+14%)
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 27.6, Growth: 11.4%) $458.76 (+38%)
Base: (SPY PE: 20.9, Growth: 11.4%) $347.94 (+5%)
Bear: (PE: 17.8, Growth: 11.4%) $295.75 (-11%)
📈 Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (40x PE), but valuation improves significantly next year (28x PE) as earnings recover.
Trailing PE: 40.18 | Current EPS (TTM): $8.48
Bull Case $531.19 (+49%)
Analyst growth 41.7%, PE expands to 44.2
Base Case $482.90 (+35%)
Market implied 41.7%, PE stable at 40.2
Bear Case $231.67 (-35%)
Severe decline -20.0%, PE contracts to 34.2
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡 Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 27.6 to 43.3
Stabilization Target: $520.45 (+56.8%)
PE Expansion Potential: +56.8%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: July 28, 2026 1:09 AM ET
Data refreshes hourly during market hours. Next update: 2:09 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
4
Buys
11
Sells
Net
INSIDERS SELLING
Recent Transactions
Ro Khanna BUY 2026-03-23
Myriam Curet SELL 105 shares 2026-03-10
Mark Brosius SELL 645 shares 2026-03-09

Unlock Insider Activity

See real-time buying/selling by company executives for ISRG.

Create Free Account

Already have an account? Log In

Top Rated Medical Instruments & Supplies Stocks

Top-rated stocks in Medical Instruments & Supplies by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
ALC
Alcon AG
STRONG BUY
27 analysts
$87 50 HOLD
RGEN
Repligen Corporation
STRONG BUY
19 analysts
$178 53 HOLD
WST
West Pharmaceutical Serv…
STRONG BUY
13 analysts
$397 51 HOLD
RMD
ResMed Inc
BUY
19 analysts
$249 49 HOLD
COO
The Cooper Companies, Inc
BUY
19 analysts
$82 51 HOLD

Advanced ISRG Option Strategies

Professional options setups generated by AI based on today's ISRG price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for ISRG

ISRG Technical Chart ISRG Price Prediction ISRG Earnings Date ISRG Investment Advisor ISRG Fair Price Analyzer ISRG Options Advisor ISRG Options Chain ISRG Options Analysis ISRG Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals